Mycobacterium Infections, Nontuberculous Clinical Trial
Official title:
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobact
The main objective of this study is to evaluate the efficacy of ALIS (amikacin liposome inhalation suspension) + background regimen (azithromycin [AZI] + ethambutol [ETH]) compared to the ELC (empty liposome control) + background regimen on participant-reported respiratory symptoms at Month 13.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03038178 -
Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease
|
Phase 2 | |
Active, not recruiting |
NCT04922554 -
Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)
|
Phase 2 | |
Terminated |
NCT04154826 -
Recombinant Interleukin-7 (CYT107) to Treat Patients With Refractory Nontuberculous Mycobacterial Lung Disease
|
Phase 2 | |
Completed |
NCT02344004 -
Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone
|
Phase 3 | |
Recruiting |
NCT06266442 -
M. Avium WGS During Mav-PD Treatment
|
||
Recruiting |
NCT02355015 -
A Prospective Registry For Non Tuberculous Mycobacterial (NTM) Infections
|
N/A | |
Completed |
NCT03421743 -
Pilot Trial of Inhaled Molgramostim in Nontuberculous Mycobacterial (NTM) Infection
|
Phase 2 | |
Not yet recruiting |
NCT06418711 -
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension
|
Phase 3 | |
Terminated |
NCT03597347 -
Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection
|
Phase 2 | |
Completed |
NCT02832843 -
Genome-Wide Association Study in Patients With Nontuberculous Mycobacterial Lung Disease
|
||
Completed |
NCT04677543 -
Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex
|
Phase 3 | |
Completed |
NCT02340897 -
Diagnostic Accuracy of Nontuberculous Mycobacterial Lung Disease Based on Chest CT
|
N/A | |
Completed |
NCT01315236 -
Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria
|
Phase 2 |